Wealth Enhancement Advisory Services
ORGO icon

Wealth Enhancement Advisory Services’s Organogenesis Holdings ORGO Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Buy
75,657
+25,936
+52% +$63.4K ﹤0.01% 3624
2026
Q1 		$111K Buy
49,721
+14,177
+40% +$49.1K ﹤0.01% 3296
2025
Q4 		$155K Buy
35,544
+772
+2% +$3.74K ﹤0.01% 3341
2025
Q3 		$144K Buy
34,772
+449
+1% +$2.09K ﹤0.01% 3253
2025
Q2 		$146K Sell
34,323
-9,075
-21% -$33.8K ﹤0.01% 3075
2025
Q1 		$187K Buy
43,398
+4,239
+11% +$17.1K ﹤0.01% 2644
2024
Q4 		$125K Buy
39,159
+5,551
+17% +$18.6K ﹤0.01% 2775
2024
Q3 		$96.1K Buy
+33,608
New +$94.3K ﹤0.01% 2565

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wealth Enhancement Advisory Services's ORGO Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Organogenesis Holdings (ORGO) stake by 52% in Q2 2026, buying an estimated $63.4K and bringing the position to 75,657 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #3624.

Wealth Enhancement Advisory Services first reported a position in ORGO in Q3 2024 and has held it in 8 quarters since. The position peaked at $187K in Q1 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Wealth Enhancement Advisory Services held 75,657 shares of Organogenesis Holdings worth $182K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 25,936 Organogenesis Holdings shares in Q2 2026, an estimated $63.4K.
  • Organogenesis Holdings made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3624 holding.
  • Wealth Enhancement Advisory Services first reported a position in Organogenesis Holdings in Q3 2024 and has held it in 8 quarters since.
  • Wealth Enhancement Advisory Services's Organogenesis Holdings position peaked at $187K in Q1 2025.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.